Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases | Journal of Medicinal Chemistry
JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis - ScienceDirect
IJMS | Free Full-Text | Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Rheumatoid arthritis | JAK inhibitors: The next generation of drugs for treating rheumatoid arthritis? | rheumatology.medicinematters.com
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Biomarker Research | Full Text
The role of JAK/STAT signaling pathway and its inhibitors in diseases - ScienceDirect
Current and future status of JAK inhibitors - The Lancet
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
The role of JAK/STAT signaling pathway and its inhibitors in diseases - ScienceDirect
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology
JAK-STAT Signaling Pathway - YouTube
Viruses | Free Full-Text | JAK-STAT Pathway: A Novel Target to Tackle Viral Infections
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
JAKs and STATs in Immunity, Immunodeficiency, and Cancer | NEJM
JCI - The suppressor of cytokine signaling–1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury
Hypoglycaemia following JAK inhibitor treatment in patients with diabetes | Annals of the Rheumatic Diseases
APExBIO - JAK/STAT Signaling - Signaling Pathways
JCI - JAK inhibitors in autoinflammation
The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
Understanding STAT3, the intersection of many carcinogenic signaling pathways
Frontiers | JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
JAK/STAT signaling in hematological malignancies | Oncogene
JAK inhibitors for Atopic Dermatitis – STAT!
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
Pathways: JAK-STAT Signaling | www.antibodies-online.com
